NCT03241550 - A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

July 5, 2019

Study Completion Date

July 5, 2019

Conditions

Hematological Malignancy

Interventions

DRUG

isavuconazonium sulfate - intravenous

IV infusion

DRUG

isavuconazonium sulfate - oral

Oral

Trial Locations (16)

19104

Children's Hospital of Philadelphia, Philadelphia

27710

Duke University Medical Center, Durham

30322

Emory University School of Medicine, Atlanta

33155

Nicklaus Children's Hospital, Miami

37203

The Children's Hospital at TriStar Centennial Medical Center, Nashville

40202

University of Louisville, Louisville

44106

University Hospital of Cleveland, Cleveland

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

55404

Children's Hospitals and Clinics of Minnesota, Minneapolis

60611

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago

64108

Children's Mercy Kansas City, Kansas City

75235

University of Texas Southwestern Medical Center, Dallas

77030

Texas Children's Hospital, Houston

90027

Children's Hospital Los Angeles, Los Angeles

90806

Miller Children's Hospital, Long Beach

92868

CHOC Children's Hospital of Orange County, Orange